PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment

2012-03-15
(Press-News.org) In preclinical studies, researchers at SRI International and Astraea Therapeutics have recently evaluated the role of a new drug receptor target that shows promise for the treatment of drug addiction.

This potential new drug target belongs to a class of receptors called the nicotinic acetylcholine receptors (nAChRs). One subtype of nAChRs, called alpha4beta2 is a well-known target for nicotine's addictive effects and the therapeutic effect of the smoking cessation drug varenicline. SRI researchers are now studying another, lesser-known subtype, called alpha3beta4 nAChR, which has recently shown to play a role in the addictive properties of cocaine, morphine, and nicotine.

Using AT-1001, a highly selective alpha3beta4 compound developed by Astraea Therapeutics, SRI researchers found that addiction processes could be disrupted. In preliminary studies, AT-1001 also reduced nicotine withdrawal symptoms such as anxiety.

Because addictive drugs act on the brain's "reward circuit," many people compulsively take them despite their harmful consequences. Feelings of pleasure are caused by the release of brain chemicals, or neurotransmitters, and their increased activity in the brain reward circuit. The key neurotransmitter in the reward circuit is dopamine, which produces changes in addictive behavior. Researchers speculate that disruption of the alpha3beta4 nAChR system using highly selective drugs such as AT-1001 may interrupt this reward circuitry.

"Currently, there are no therapeutics approved to treat addiction to stimulants such as cocaine, so it is intriguing to find a promising drug receptor target and to see that AT-1001 can indeed affect phenomena that are thought to be deeply tied to the addictive nature of cocaine and other drugs of abuse," said Taline Khroyan, Ph.D., Senior Behavioral Pharmacologist in SRI's Center for Health Sciences.

Findings from these collaborative studies were recently presented at the Society for Neuroscience Annual Meeting in a study titled "AT-1001, a Highly Selective alpha3beta4 nicotinic Receptor Antagonist is Effective in Blocking Place Preference, Behavioral Sensitization, and Withdrawal Effects of Various Drugs of Abuse." The presentation was highlighted by the Society for describing the innovative approach taken by the research team.

INFORMATION:

This research was funded 96% ($1,991,814) by National Institute on Drug Abuse grant R01DA020811. The remainder is from non-governmental sources.

About SRI International

Silicon Valley-based SRI International, a nonprofit research and development organization, performs sponsored R&D for governments, businesses, and foundations. SRI brings its innovations to the marketplace through technology licensing, new products, and spin-off ventures. SRI is known for world-changing innovations in computing, health and pharmaceuticals, chemistry and materials, sensing, energy, education, national defense, and more.

END



ELSE PRESS RELEASES FROM THIS DATE:

What to Do When Nursing Home Neglect Leads to Dangerous Dehydration

2012-03-15
Dehydration is one of the most common forms of nursing home neglect. The risk of dehydration is particularly acute in patients who suffer from health problems that render them incapable of properly communicating their needs. Nursing home dehydration can happen for a number of different reasons. Some patients aren't physically able to drink from a glass, either because they have difficulty swallowing or because they are unable to sit upright. In other cases, patients with cognitive or emotional difficulties may refuse certain beverages. In the worst cases the neglect ...

More than half of Americans doubt US global leadership in 2020

2012-03-15
WASHINGTON—March 14, 2012—More than half of likely voters doubt that the United States will be the No. 1 world leader in science, technology and health care by the year 2020, according to a new national public opinion poll commissioned by Research!America. The findings reveal deep concerns among Americans about the country's ability to maintain its world-class status in innovation, research and development before the next decade. "A lackluster investment in science and innovation is driving fears among Americans about our world dominance in the years ahead," said Research!America ...

Study demonstrates cells can acquire new functions through transcriptional regulatory network

2012-03-15
Researchers at the RIKEN Omics Science Center (OSC) have successfully developed and demonstrated a new experimental technique for producing cells with specific functions through the artificial reconstruction of transcriptional regulatory networks. As an alternative to induced pluripotent stem cells, the technique promises to enable faster and more efficient production of functional cells for use in cancer therapy and a variety of other areas. Starting with the first-ever production of induced pluripotent stem cells (iPS cells) in 2006, cell reprogramming - the genetic ...

Genome-wide study reveals how key immune sensors arrive at the front lines of infection

Genome-wide study reveals how key immune sensors arrive at the front lines of infection
2012-03-15
LA JOLLA, Calif., March 14, 2012 – In a healthy immune system, invading pathogens trigger a cascade of alerts and responses to fight off the infection. Sensors called toll-like receptors, or TLRs, act as one of the first lines of defense. Two of these sensors, known as TLR7 and TLR9, specifically recognize and respond to microbial RNA and DNA, respectively. But what determines how these TLRs get where they need to be and sound the alarm for pathogen infection? To answer this question, a team led by Sumit Chanda, Ph.D. and colleagues at Sanford-Burnham Medical Research Institute ...

Breakthroughs in Chikungunya research from A*STAR spell new hope for better treatment and protection

2012-03-15
Recent breakthroughs in Chikungunya research spearheaded by scientists at A*STAR's Singapore Immunology Network (SIgN) have made great strides in the battle against the infectious disease. Working in close collaborations with Singapore clinician-scientists and international researchers , Dr Lisa Ng, Principal Investigator of the Chikungunya research group at SIgN, led the team to discover a direct biomarker which serves as an early and accurate prognosis of patients who have a higher risk of the more severe form of Chikungunya fever (CHIKF). This means that doctors can ...

Texas Paternity Fraud: I'm Not the Father So Why the Child Support?

2012-03-15
What if a man has been named the father of a child, but has to pay child support because he missed court or was misled into signing a paternity statement without a DNA test? Although the Texas Family Code covers a wide range of legal issues from divorce, child custody and spousal support to modifications of custody and visitation because of parental relocation, one Texas paternity provision was recently changed regarding the need to correct paternity mistakes with DNA testing. Prior to the passage of Texas Senate Bill 785, a man could only request a paternity test prior ...

UN emission market needs urgent reform

2012-03-15
The United Nations (UN) global carbon market requires substantial reform because it too often fails to support the projects and people it is meant to help, according to new research from the Economic and Social Research Council (ESRC). The research findings are released as the UN, which has designated 2012 the International Year of Sustainable Energy for All, begins a policy dialogue about its Clean Development Mechanism (CDM), under which companies are allocated tradable credits if they pay others to cut their carbon emissions. The CDM is designed to help finance ...

Anesthetists test scale that measures risk of harm from invasive research placebos

2012-03-15
A scale developed to measure the potential harm caused by invasive placebos in local anaesthesia research has been successfully tested by a group of 43 independent clinicians, according to research published in the April issue of Anaesthesia. The consultant anaesthetists were asked to assess the risk of harm posed by control group interventions described in ten published clinical anaesthesia studies using the Serious Harm and Morbidity (SHAM) scale. There was substantial agreement between the 22 consultants who were given clinical examples to illustrate the scale ...

Change on the Horizon for Small Claim Copyright Infringement?

2012-03-15
An exclusive right to produced work is cemented within the Constitution. When works of art, works of authorship or screenplays are produced, the creators have the right to protect their works. These protections are provided by the federal Copyright Act, which has a broad reach, including both small, individual works and colossal, multimillion-dollar movie productions. Just as the range of protected work varies, so do the resources available to bring lawsuits claiming copyright infringement. Those attempting to file suits for relatively small claims are often dissuaded ...

Researchers attempt to solve problems of antibiotic resistance and bee deaths in one

2012-03-15
The stomachs of wild honey bees are full of healthy lactic acid bacteria that can fight bacterial infections in both bees and humans. A collaboration between researchers at three universities in Sweden – Lund University, the Swedish University of Agricultural Sciences and Karolinska Institutet – has produced findings that could be a step towards solving the problems of both bee deaths and antibiotic resistance. The researchers have now published their results in the scientific journal PLoS ONE and the legendary science photographer Professor Lennart Nilsson from Karolinska ...

LAST 30 PRESS RELEASES:

Video consultations are faster, cheaper and more sustainable for patients

Neuroscience drives new wellbeing app

MOVEO project kicks off in Málaga to shape the future of smarter, smoother mobility across Europe

Are the rest of podcasters history? AI-generated podcasts open new doors to make science accessible

Two frontiers: Illinois experts combine forces to develop novel nanopore sensing platform

Biotechnology governance entreaties released, echoing legacy of 1975 recombinant DNA guidelines

Review of active distribution network reconfiguration: Past progress and future directions

Revealing the lives of planet-forming disks

What’s really in our food? A global look at food composition databases and the gaps we need to fix

Racial differences in tumor collagen structure may impact cancer prognosis

Museomics highlights the importance of scientific museum collections

Fossil corals point to possibly steeper sea level rise under a warming world

The quantum mechanics of chiral spin selectivity

Bodybuilding in ancient times: How the sea anemone got its back

Science and innovation for a sustainable future

Strange radio pulses detected coming from ice in Antarctica

Amazon trees under pressure: New study reveals how forest giants handle light and heat

Cell-depleting treatment in severe RMD: New data

Vasodilation in systemic sclerosis

New ideas in gout management

Risk factors for progression in spondyloarthritis

Patient experiences In JIA

Patient organizations: The partner by your side

Nurses: A critical role for people with RMD

Online information for patients needs guidance

The many ways that AI enters rheumatology

Pregnancy outcomes in autoinflammatory disease

The value of physical activity for people with RMD

First data from the EULAR RheumaFacts project

Research spotlight: Preventing stalling to improve CAR-T cells’ efficacy against tumors

[Press-News.org] Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment